20 mL blood or 0.5-1.0 mL bone marrow in preservative free Lithium heparin ( no gel)
These studies are generally performed for additional diagnostic information at the time of marrow biopsy in patients with acute leukaemia, myeloproliferative disorders and stem cell transplant recipients. |